Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Other Non-Current Assets (2016 - 2019)

Ascendis Pharma A (ASND) has disclosed Other Non-Current Assets for 4 consecutive years, with $1.6 million as the latest value for Q4 2019.

  • Quarterly Other Non-Current Assets rose 22.52% to $1.6 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2019, up 22.52% year-over-year, with the annual reading at $1.6 million for FY2019, 22.52% up from the prior year.
  • Other Non-Current Assets hit $1.6 million in Q4 2019 for Ascendis Pharma A, up from $1.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.6 million in Q4 2019 to a low of $74178.2 in Q4 2017.
  • Historically, Other Non-Current Assets has averaged $826164.5 across 4 years, with a median of $805551.6 in 2016.
  • Biggest five-year swings in Other Non-Current Assets: crashed 74.37% in 2017 and later skyrocketed 1681.84% in 2018.
  • Year by year, Other Non-Current Assets stood at $289366.1 in 2016, then plummeted by 74.37% to $74178.2 in 2017, then surged by 1681.84% to $1.3 million in 2018, then grew by 22.52% to $1.6 million in 2019.
  • Business Quant data shows Other Non-Current Assets for ASND at $1.6 million in Q4 2019, $1.3 million in Q4 2018, and $74178.2 in Q4 2017.